ArticleOncotarget2015

miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.

Hyun Joo Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.